By assessing the microRNAs floating in a person's blood, startup Miroculus aims to aid in the early diagnosis of cancer, Wired reports.

Fay Christodoulou and her colleagues formed Miroculus after meeting at the Silicon Valley incubator Singularity University to make a low-cost, open-source diagnostic they called Miriam. Their goal is for untrained workers in clinics around the world to be able to use Miriam to screen for cancer.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.